4//SEC Filing
Resnick Joshua 4
Accession 0001104659-21-088387
CIK 0001798749other
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 6:36 PM ET
Size
6.0 KB
Accession
0001104659-21-088387
Insider Transaction Report
Form 4
Resnick Joshua
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-29+25,000→ 25,000 totalExercise: $14.00Exp: 2031-06-28→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]This option shall vest in 36 substantially equal monthly installments, with the first installment vesting on July 29, 2021.
- [F2]Under the Reporting Person's arrangement with RA Capital Management, L.P. (the "Adviser"), the Reporting Person holds the option for the benefit of the RA Capital Healthcare Fund, L.P. (the "Fund") and RA Capital Nexus Fund, L.P. (the "Nexus Fund"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received upon exercise of the option, which will offset advisory fees owed by the Fund and Nexus Fund to the Adviser. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock.
Documents
Issuer
Aerovate Therapeutics, Inc.
CIK 0001798749
Entity typeother
Related Parties
1- filerCIK 0001690959
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 6:36 PM ET
- Size
- 6.0 KB